Health Catalyst Inc
NASDAQ:HCAT

Watchlist Manager
Health Catalyst Inc Logo
Health Catalyst Inc
NASDAQ:HCAT
Watchlist
Price: 2.42 USD 1.68% Market Closed
Market Cap: 171.2m USD

Wall Street
Price Targets

HCAT Price Targets Summary
Health Catalyst Inc

Wall Street analysts forecast HCAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HCAT is 4.02 USD with a low forecast of 3.03 USD and a high forecast of 5.25 USD.

Lowest
Price Target
3.03 USD
25% Upside
Average
Price Target
4.02 USD
66% Upside
Highest
Price Target
5.25 USD
117% Upside
Health Catalyst Inc Competitors:
Price Targets
2413
M3 Inc
36% Upside
INSP
Inspire Medical Systems Inc
51% Upside
OPRX
OPTIMIZERx Corp
99% Upside
EQS
Equasens SA
18% Upside
CERT
Certara Inc
44% Upside
ALMDT
Median Technologies SA
98% Upside
DOCS
Doximity Inc
59% Upside
GPI
GPI SpA
17% Upside

Revenue
Forecast

Revenue Estimate
Health Catalyst Inc

For the last 6 years the compound annual growth rate for Health Catalyst Inc's revenue is 18%. The projected CAGR for the next 4 years is 2%.

18%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Health Catalyst Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
55%
Average Beat

Net Income
Forecast

Net Income Estimate
Health Catalyst Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HCAT's stock price target?
Price Target
4.02 USD

According to Wall Street analysts, the average 1-year price target for HCAT is 4.02 USD with a low forecast of 3.03 USD and a high forecast of 5.25 USD.

What is Health Catalyst Inc's Revenue forecast?
Projected CAGR
2%

For the last 6 years the compound annual growth rate for Health Catalyst Inc's revenue is 18%. The projected CAGR for the next 4 years is 2%.

Back to Top